Long-Term Mortality of Coronary Artery Bypass Graft Surgery and Stenting With Drug- Eluting Stents Chuntao Wu, MD, PhD, Fabian T. Camacho, MS, Songyang Zhao, MS, Andrew S. Wechsler, MD, Alfred T. Culliford, MD, Stephen J. Lahey, MD, Spencer B. King, MD, Gary Walford, MD, Jeffrey P. Gold, MD, Craig R. Smith, MD, Desmond Jordan, MD, Robert S.D. Higgins, MD, Edward L. Hannan, PhD The Annals of Thoracic Surgery Volume 95, Issue 4, Pages 1297-1305 (April 2013) DOI: 10.1016/j.athoracsur.2012.11.073 Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 (A–F). Kaplan-Meier survival curves for coronary artery bypass grafting (CABG) and stenting patients: (A) All patients; (B) 3 diseased vessels with diseased proximal left anterior descending (LAD) artery; (C) 3 diseased vessels with diseased nonproximal LAD artery; (D) 2 diseased vessels with diseased proximal LAD artery; (E) 2 diseased vessels with diseased nonproximal LAD artery; and (F) 2 diseased vessels without diseased LAD artery. (- - - = CABG; — = stenting.) The Annals of Thoracic Surgery 2013 95, 1297-1305DOI: (10.1016/j.athoracsur.2012.11.073) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 (A)–(F). Kaplan-Meier survival curves for propensity-matched coronary artery bypass grafting (CABG) and stenting patients. (A) All patients; (B) 3 diseased vessels with diseased proximal left anterior descending (LAD) artery; (C) 3 diseased vessels with diseased nonproximal LAD artery; (D) 2 diseased vessels with diseased proximal LAD artery; (E) 2 diseased vessels with diseased nonproximal LAD artery; and (F) 2 diseased vessels without diseased LAD artery. (- - - = CABG; — = stenting.) The Annals of Thoracic Surgery 2013 95, 1297-1305DOI: (10.1016/j.athoracsur.2012.11.073) Copyright © 2013 The Society of Thoracic Surgeons Terms and Conditions